​
​

Celcuity (CELC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CELC Stock Forecast

Celcuity stock forecast is as follows: an average price target of $31.50 (represents a 146.48% upside from CELC’s last price of $12.78) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

CELC Price Target

The average price target for Celcuity (CELC) is $31.50 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $39.00 to $24.00. This represents a potential 146.48% upside from CELC's last price of $12.78.

CELC Analyst Ratings

Buy

According to 5 Wall Street analysts, Celcuity's rating consensus is 'Buy'. The analyst rating breakdown for CELC stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Celcuity Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 15, 2024Bradley CaninoStifel Nicolaus$39.00$16.57135.37%205.16%
May 30, 2024Bradley CaninoStifel Nicolaus$40.00$15.28161.78%212.99%
Mar 28, 2024Gil BlumNeedham$24.00$18.1632.16%87.79%
Row per page
Go to

The latest Celcuity stock forecast, released on Aug 15, 2024 by Bradley Canino from Stifel Nicolaus, set a price target of $39.00, which represents a 135.37% increase from the stock price at the time of the forecast ($16.57), and a 205.16% increase from CELC last price ($12.78).

Celcuity Price Target by Period

1M3M12M
# Anlaysts--3
Avg Price Target--$34.33
Last Closing Price$12.78$12.78$12.78
Upside/Downside-100.00%-100.00%168.62%

In the current month, the average price target of Celcuity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Celcuity's last price of $12.78. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2024Cowen & Co.BuyBuyHold
Jul 22, 2024JefferiesBuyBuyHold
Mar 28, 2024Craig-HallumBuyBuyHold
Mar 28, 2024NeedhamBuyBuyHold
Oct 11, 2021Canaccord Genuity-BuyInitialise
Row per page
Go to

Celcuity's last stock rating was published by Cowen & Co. on Aug 15, 2024. The company gave CELC a "Buy" rating, the same as its previous rate.

Celcuity Financial Forecast

Celcuity Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue-----------
Avg Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
High Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
Low Forecast$28.60M$14.30M$92.80M$92.80M$1.27M$550.00K--$4.41M$1.89M-
# Analysts444433--45-
Surprise %-----------

Celcuity's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CELC's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Celcuity EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
EBITDA-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

undefined analysts predict CELC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Celcuity's previous annual EBITDA (undefined) of $NaN.

Celcuity Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
Net Income-----------
Avg Forecast$-22.68M$-30.38M$-35.95M$-32.52M$-34.41M$-32.52M$-31.84M$-29.70M$-30.32M$-27.94M$-26.09M
High Forecast$-22.68M$-30.38M$-35.95M$-32.52M$-34.41M$-32.52M$-31.84M$-26.27M$-27.83M$-27.94M$-26.09M
Low Forecast$-22.68M$-30.38M$-35.95M$-32.52M$-34.41M$-32.52M$-31.84M$-32.74M$-32.40M$-27.94M$-26.09M
Surprise %-----------

Celcuity's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CELC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Celcuity SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
SG&A-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

Celcuity's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CELC last annual SG&A of $NaN (undefined).

Celcuity EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts444433--45-
EPS-----------
Avg Forecast$-0.53$-0.71$-0.84$-0.76$-0.80$-0.76$-0.74$-0.69$-0.71$-0.65$-0.68
High Forecast$-0.53$-0.71$-0.84$-0.76$-0.80$-0.76$-0.74$-0.61$-0.65$-0.65$-0.68
Low Forecast$-0.53$-0.71$-0.84$-0.76$-0.80$-0.76$-0.74$-0.77$-0.76$-0.65$-0.68
Surprise %-----------

According to undefined Wall Street analysts, Celcuity's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CELC previous annual EPS of $NaN (undefined).

Celcuity Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
HOWLWerewolf Therapeutics$1.64$12.00631.71%Buy
ANTXAN2 Therapeutics$1.30$8.75573.08%Buy
MOLNMolecular Partners$5.20$29.00457.69%Buy
AVTEAerovate Therapeutics$2.66$13.00388.72%Hold
ANEBAnebulo Pharmaceuticals$1.52$6.00294.74%Buy
ACRVAcrivon Therapeutics$6.50$21.83235.85%Buy
CCCCC4 Therapeutics$4.05$13.50233.33%Buy
RZLTRezolute$5.01$13.50169.46%Buy
ANABAnaptysBio$20.31$52.00156.03%Buy
CELCCelcuity$12.78$31.50146.48%Buy
ADAGAdagene$2.09$5.00139.23%Buy
MLYSMineralys Therapeutics$12.60$30.00138.10%Buy
EWTXEdgewise Therapeutics$31.95$45.0040.85%Buy
IKNAIkena Oncology$1.70$1.33-21.76%Buy
CYTCyteir Therapeutics$3.02$2.00-33.77%Sell

CELC Forecast FAQ

Is Celcuity a good buy?

Yes, according to 5 Wall Street analysts, Celcuity (CELC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of CELC's total ratings.

What is CELC's price target?

Celcuity (CELC) average price target is $31.5 with a range of $24 to $39, implying a 146.48% from its last price of $12.78. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Celcuity stock go up soon?

According to Wall Street analysts' prediction for CELC stock, the company can go up by 146.48% (from the last price of $12.78 to the average price target of $31.5), up by 205.16% based on the highest stock price target, and up by 87.79% based on the lowest stock price target.

Can Celcuity stock reach $20?

CELC's average twelve months analyst stock price target of $31.5 supports the claim that Celcuity can reach $20 in the near future.

What are Celcuity's analysts' financial forecasts?

Celcuity's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.82M (high $1.82M, low $1.82M), average EBITDA is $0 (high $0, low $0), average net income is $-128M (high $-125M, low $-132M), average SG&A $0 (high $0, low $0), and average EPS is $-3.002 (high $-2.922, low $-3.073). CELC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $228.5M (high $228.5M, low $228.5M), average EBITDA is $0 (high $0, low $0), average net income is $-122M (high $-122M, low $-122M), average SG&A $0 (high $0, low $0), and average EPS is $-2.84 (high $-2.84, low $-2.84).